Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Events

Events

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Events
  • FDA
  • News

Allogene Therapeutics Highlights Phase 1 Data On ALLO-501 And ALLO-501A In Relapsed/Refractory Non-Hodgkin Lymphoma At 2021 ASCO Meeting

By Benzinga Newsdesk
Today, 3:48 AM
ASCO Posters Detail Results from ALLO-501 ALPHA and ALLO-501A ALPHA2 Trials in Non-Hodgkin Lymphoma and Safety and PK/PD Data of ALLO-647 with Flu/Cy Across the ALPHA, ALPHA2 and UNIVERSAL Studies Results from

ALLO

Read More
2 minute read
  • Events
  • FDA
  • News

TRACON Pharmaceuticals Presents Data From Phase 1 Study Of Uliledlimab (TJ004309) And Tecentriq (Atezolizumab) At ASCO Meeting

By Benzinga Newsdesk
Today, 3:48 AM
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, today presented updated data from the

TCON

Read More
2 minute read
  • Events
  • FDA
  • News

Curis To Host Virtual Event To Discuss Updated Clinical Data For CA-4948 In AML/MDS Presented At EHA

By Benzinga Newsdesk
Today, 3:48 AM
Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event to discuss progress to date for

CRIS

Read More
1 minute read
  • Events
  • Federal Reserve
  • News

Fed Chair Jay Powell To Speak On ‘Central banks and climate change’ At the Green Swan 2021 Global Virtual Conference 7 a.m. EDT

By Benzinga Newsdesk
Today, 3:48 AM
https://www.youtube.com/user/bisbribiz

SPY

Read More
2 minute read
  • Cannabis
  • Events
  • Interview
  • Markets
  • News

Canopy Growth Exec: CBD Beverage Market Will Hit $1.5B In Coming Years

By Wayne Duggan
Today, 3:48 AM
Tara Rozalowsky, vice president of beverages and edibles at Canopy Growth Corp (NASDAQ: CGC), discussed the latest developments on the CBD front at the Benzinga Cannabis Capital Conference on Thursday.

CGC

Read More
3 minute read
  • Biotech
  • Events
  • General
  • News

Albireo Pharma Highlights Presentation Of Data From Phase 3 PEDFIC Study

By Bill Haddad
Today, 3:48 AM
 Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today presented clinical data from its Phase 3 PEDFIC 1 study and an interim data cut of the

ALBO

Read More
1 minute read
  • Events
  • News

From BZ Cannabis Capital Conference: AFC Gamma CEO Says Company Will See ‘Massive Demand’ In New York’s $5B Market

By Benzinga Newsdesk
Today, 3:48 AM
https://www.youtube.com/watch?v=7IZ5xoMfqXs

AFCG

Read More
2 minute read
  • Events
  • Interview
  • Management
  • News
  • Small Cap

EXCLUSIVE: Chromadex CEO To Ring Nasdaq Closing Bell, Talks Walmart Product Launch

By Wayne Duggan
Today, 3:48 AM
Chromadex Corp (NASDAQ: CDXC) is participating in the Nasdaq’s closing bell ceremony on Thursday afternoon to celebrate its five-year anniversary of trading on the exchange.

CDXC

Read More
1 minute read
  • Earnings
  • Events
  • News

From BZ Cannabis Capital Conference: GrowGeneration CEO Notes Co. Just Reported 13th Consecutive Quarter Of Year-Over-Year Growth

By Benzinga Newsdesk
Today, 3:48 AM
https://www.youtube.com/watch?v=py4lOK804MM

GRWG

Read More
1 minute read
  • Events
  • News
  • Tech

Tesla Recalls 734 Model 3 EVs Shipped To China Over Seat Belt, Tire Issues

By Rachit Vats
Today, 3:48 AM
Tesla Inc (NASDAQ: TSLA) is recalling 734 units of its mid-size sedan Model 3, CNBC reported on Thursday — citing China's State Administration for Market Regulation. 

TSLA

Posts navigation

Previous 1 … 163 164 165 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service